This process generated a final study sample of FSWs of 5,498.
Finally, we excluded all those with any diagnosis code for retinopathy or maculopathy recorded until the first diagnosis of diabetes resulting in a final study cohort of 121,834 diabetic patients (55% of them were men).
This resulted in a final study sample of 280 women, of which 52 (18.6%) had self-reported MM and 228 (81.4%) had non-menstrual migraine (nMM) (Fig. 1).
Two questionnaires were completed by subjects outside of the predetermined age range resulting in a final study sample of 1,131 participants, or 55% of the sample population.
Thus, a final study cohort of 350 subjects (65% of parent trial) was available for this analysis.
This left a final study population of 17,585, with 534 cases of diagnosed depression and 17,051 controls who had complete information for analyses.
After further restricting the sample to those patients whose index hospitalization was ≥4, but ≤30 days and excluding admissions at non-acute care hospitals, we obtained a final study sample of 4,105 patients (48.8% of the original hospitalization sample drawn).
This method of elimination resulted in a final study cohort of 725 non-diabetic individuals.
Application of these criteria yielded a final study group of 69 children and adolescents.
